問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2018-10-24 - 2024-03-31
Condition/Disease
Obesity
Test Drug
Semaglutide B 3.0 mg/mL PDS290 or Semaglutide placebo
Participate Sites6Sites
Recruiting4Sites
Terminated2Sites
Division of Cardiovascular Diseases
2019-08-20 - 2022-03-01
Diabetes Mellitus, Type 2
Semaglutide Tablets
Participate Sites4Sites
Terminated4Sites
2019-08-01 - 2022-03-31
type 2 diabetes mellitus
Participate Sites3Sites
Terminated3Sites
2005-05-01 - 2006-12-31
2009-01-19 - 2010-08-31
2011-05-23 - 2012-10-31
2016-05-06 - 2017-08-16
2013-02-21 - 2016-02-28
2016-06-01 - 2020-08-17
Participate Sites2Sites
2017-08-28 - 2019-10-02
Division of Endocrinology
全部
